SCHEMBL21780949

SCHEMBL21780949

COc1ccc(C2C=CCCC2C(C)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
TP53 P04637 1/20 0.39
KMT2A Q03164 3/20 0.38
GAA P10253 3/20 0.38
LMNA P02545 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
POLB P06746 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
EDNRB P24530 1/20 0.37
EDNRA P25101 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
TSHR P16473 1/20 0.37
RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12577524 0.72 RAB9A (0.57) MAPTRAB9ANPC1ALDH1A1LMNA
SCHEMBL16397928 0.72 ALOX15 (0.45) MAPTRAB9ANPC1ALDH1A1KDM4E
SCHEMBL16397926 0.72 ALOX15 (0.45) MAPTRAB9ANPC1ALDH1A1KDM4E
SCHEMBL8096846 0.71 SLC6A4 (0.49) MAPTHSD17B10POLBTSHR
SCHEMBL7828978 0.71 SLC6A4 (0.49) MAPTHSD17B10POLBTSHR
SCHEMBL28348174 0.71 PDE4B (0.47) RAB9AALDH1A1TP53GAASMN1; SMN2
SCHEMBL21768005 0.71 PDE4B (0.47) RAB9AALDH1A1TP53GAASMN1; SMN2
SCHEMBL21768003 0.71 PDE4B (0.47) RAB9AALDH1A1TP53GAASMN1; SMN2
SCHEMBL8096658 0.67 AKR1C3 (0.44) RAB9ANPC1ALDH1A1KMT2AGAA
SCHEMBL7824679 0.67 AKR1C3 (0.44) RAB9ANPC1ALDH1A1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3616692-A1 PHARMACEUTICAL COMPOSITION, CONTAINING NM23 ACTIVATOR, FOR INHIBITING CANCER METASTASIS Ewha University-Industry Collaboration Foundation (KR) 2020-03-04 EP disclosed